Literature DB >> 2253297

Amyloidosis associated bleeding diatheses in the surgical patient.

A R Mizutani1, C F Ward.   

Abstract

The coagulopathies associated with amyloidosis have not been widely appreciated. We encountered a patient with amyloidosis and mildly abnormal coagulation studies who presented for an emergency laparotomy for acute bowel obstruction. Upon gentle manipulation of the bowel, an unexpected bleeding diathesis was manifested by the formation of several large haematomas resulting in a large amount of blood loss (approximately 800 ml). Numerous defects of platelet function and coagulation have been associated with amyloidosis, including abnormal platelet aggregation, increased vascular fragility, factor IX and X deficiencies, decreased levels of alpha-2-plasmin inhibitor, and increased levels of plasminogen. Intraoperative therapy for our patient included the rapid administration of four units of fresh frozen plasma and ten units of platelet concentrate. A review of the pathology and therapeutic modalities for this potentially life-threatening complication is presented.

Entities:  

Mesh:

Year:  1990        PMID: 2253297     DOI: 10.1007/BF03006634

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  AMYLOIDOSIS ASSOCIATED WITH FACTOR X (STUART) DEFICIENCY; CASE REPORT.

Authors:  L PECHET; J J KASTRUL
Journal:  Ann Intern Med       Date:  1964-08       Impact factor: 25.391

2.  Intravascular coagulation in systemic amyloidosis.

Authors:  E J Bowie; E Maldonado; A L Brown; P Didisheim; C A Owen
Journal:  Thromb Diath Haemorrh Suppl       Date:  1969

3.  The cutaneous amyloidoses. II. Systemic forms.

Authors:  M H Brownstein; E B Helwig
Journal:  Arch Dermatol       Date:  1970-07

Review 4.  Acquired disorders of platelet function.

Authors:  T W Malpass; L A Harker
Journal:  Semin Hematol       Date:  1980-10       Impact factor: 3.851

5.  Mechanism of factor X deficiency in systemic amyloidosis.

Authors:  B Furie; L Voo; K P McAdam; B C Furie
Journal:  N Engl J Med       Date:  1981-04-02       Impact factor: 91.245

6.  Amyloidosis: review of 236 cases.

Authors:  R A Kyle; E D Bayrd
Journal:  Medicine (Baltimore)       Date:  1975-07       Impact factor: 1.889

7.  Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.

Authors:  J C Chang; K K Kane
Journal:  Am J Clin Pathol       Date:  1984-03       Impact factor: 2.493

8.  Coagulopathy in amyloidosis: combined deficiency of factors IX and X.

Authors:  R A McPherson; J W Onstad; R J Ugoretz; P L Wolf
Journal:  Am J Hematol       Date:  1977       Impact factor: 10.047

Review 9.  Factor-X deficiency in amyloidosis: a critical review.

Authors:  P R Greipp; R A Kyle; E J Bowie
Journal:  Am J Hematol       Date:  1981-12       Impact factor: 10.047

10.  Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.

Authors:  H Takahashi; T Koike; N Yoshida; O Kitahara; M Hanano; A Shibata; N Aoki
Journal:  Am J Hematol       Date:  1986-10       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.